2023

1. Rationale for combined therapies in severe-to-critical COVID-19 patients

   Frontiers in Immunology, Vol. 14

2. Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism

   Annals of the Rheumatic Diseases, Vol. 82, Núm. 12, pp. 1594-1605